Related Experiment Video
Updated: Apr 7, 2026

10:23
Author Spotlight: Optimization of Ultrashort Peptide Matrices for Colorectal Cancer Organoids
Published on: May 3, 2024
1.6K
Electrospun PLA/PCL Composite Scaffolds as Platforms for Investigating Colorectal Cancer Cell Plasticity.
Shraddha Chakraborty1, Blesson Tom Mathew2, Ritu Kulshreshtha1
1Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, New Delhi 110016, India.
ACS Omega
|April 6, 2026
Summary
Electrospun nanofibrous scaffolds offer advanced in vitro colorectal cancer (CRC) modeling. PLA/PCL scaffolds enhance cell adhesion and proliferation, improving preclinical cancer research.
Area of Science:
- Biomaterials Science
- Cancer Biology
- Tissue Engineering
Background:
- Electrospun nanofibrous scaffolds provide tunable, biocompatible platforms for in vitro cancer modeling.
- Current 2D cell cultures lack the complexity for accurate preclinical cancer testing.
Purpose of the Study:
- To compare the effects of polylactic acid (PLA), polycaprolactone (PCL), and a PLA/PCL blend scaffold on colorectal cancer (CRC) cell lines.
- To evaluate the potential of these scaffolds in advancing in vitro CRC modeling and therapeutic testing.
Main Methods:
- Fabrication and characterization of PLA, PCL, and PLA/PCL electrospun nanofibrous scaffolds.
- Assessment of scaffold morphology, physicochemical properties, and biocompatibility.
- Analysis of CRC cell (HT-29, HCT116) responses including morphology, viability, proliferation, metabolism, and gene expression.
Main Results:
- Scaffolds exhibited uniform, bead-free fibers with minor changes in crystallinity and hydrophobicity.
- PLA/PCL scaffolds promoted enhanced cell adhesion, proliferation, and sustained metabolic activity.
- Gene expression analysis revealed upregulation of EMT, ECM, stemness, and adhesion markers, with cell-line-specific responses.
Conclusions:
- PLA/PCL electrospun scaffolds show promise for bridging 2D and 3D in vitro models for CRC.
- These composite scaffolds can significantly advance colorectal cancer modeling and preclinical therapeutic evaluations.

